| Literature DB >> 26113867 |
Mario Augusto Bolaños-Carrillo1, Jose Luis Ventura-Gallegos2, Arturo David Saldivar-Jiménez2, Alejandro Zentella-Dehesa3, Mariano Martínez-Vázquez1.
Abstract
Objective. To explore the effect of peniocerol and macdougallin on HCT-15 and MCF-7 cells proliferation, cell cycle, apoptosis, and PARP cleavage. Methods. HCT-15 and MCF-7 cells were treated with various concentrations of peniocerol and macdougallin (10-80 μM) during 24 or 48 h. Crystal Violet Assay was used to evaluate the inhibition effect. Cell cycle regulation was examined by a propidium iodide method. Cell apoptosis was detected through both Annexin-V FLUOS/PI double-labeled cytometry assays and Western blot was applied to assess PARP cleavage. Results. Peniocerol and macdougallin induced growth inhibition and apoptosis in vitro in a time- and dose-dependent manner. Moreover, peniocerol and macdougallin induced arrest of cell cycle-dependent manner and increased the proportion of cells in G0/G1 phase. PARP cleavage in HCT-15 and MCF-7 cells was induced by treatment with peniocerol and macdougallin after 36 hours. Conclusions. Our results showed that the mechanism of cytotoxicity displayed by peniocerol and macdougallin is related to cell cycle arrest and apoptosis in both cell lines. This is a significant observation because it helps to understand the way some oxysterols isolated from Myrtillocactus geometrizans develop their biological activities against cancer cells.Entities:
Year: 2015 PMID: 26113867 PMCID: PMC4465765 DOI: 10.1155/2015/589350
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Cytotoxicity (IC50) of peniocerol and macdougallin in HCT-15 and MCF-7 cancer cells.
| Compound | Human cancer cell lines | IC50 value ( | Incubation time (hour) |
|---|---|---|---|
| Peniocerol | HCT-15 | 41.66 ± 0.41 | 24 |
| 28.85 ± 0.60 | 48 | ||
| MCF-7 | 48.17 ± 0.35 | 24 | |
| 21.77 ± 0.39 | 48 | ||
|
| |||
| Macdougallin | HCT-15 | 37.67 ± 0.76 | 24 |
| 33.71 ± 0.84 | 48 | ||
| MCF-7 | 31.83 ± 1.06 | 24 | |
| 28.15 ± 0.54 | 48 | ||
|
| |||
| Doxorubicin (DOX) | HCT-15 | 0.36 ± 0.03 | 24 |
| 0.16 ± 0.02 | 48 | ||
| MCF-7 | 0.37 ± 0.02 | 24 | |
| 0.28 ± 0.01 | 48 | ||
HCT-15: colorectal adenocarcinoma. MCF-7: breast adenocarcinoma.
Values are expressed as mean ± S.D of three independent experiments, each made in triplicate.
Figure 1Annexin V/PI assay. HCT-15 cells treated with peniocerol (3) or macdougallin (4) at 40 and 60 μM concentrations. Values are expressed as mean + S.D. of three independent experiments, each made in triplicate.
Percentage of apoptosis induced by peniocerol or macdougallin in HCT-15 cell line.
| Treatment | Percentage of apoptosis (%) |
|---|---|
| (A) Control, HCT-15, 24 h | 7.14 ± 1.13% (EA) |
| 0.24 ± 0.11% (LA) | |
|
| |
| (B) Peniocerol 40 | 51.96 ± 5.54% (EA) |
| 0.11 ± 0.06% (LA) | |
|
| |
| (C) Peniocerol 60 | 73.36 ± 4.20% (EA) |
| 14.60 ± 2.53% (LA) | |
|
| |
| (D) Macdougallin 40 | 63.30 ± 0.42% (EA) |
| 1.39 ± 0.22% (LA) | |
|
| |
| (E) Macdougallin 60 | 77.63 ± 2.81% (EA) |
| 0.04 ± 0.05% (LA) | |
EA: early apoptosis, LA: late apoptosis.
Values are expressed as mean + S.D. of three independent experiments, each made in triplicate.
Figure 2Annexin V/PI assay. MCF-7 cells treated with peniocerol and macdougallin at 48 h (40 μM each one).
Percentage of apoptosis induced by peniocerol or macdougallin in MCF-7 cell line.
| Treatment | Percentage of apoptosis (%) |
|---|---|
| (A) Control, MCF-7, 48 h | 11 ± 3% (EA) |
| 0.36 ± 0.15 (LA) | |
|
| |
| (B) Peniocerol 40 | 83 ± 2% (EA) |
| 0.23 ± 0.12 (LA) | |
|
| |
| (C) Macdougallin 40 | 66 ± 3% (EA) |
| 1.27 ± 6% (LA) | |
EA: early apoptosis, LA: late apoptosis.
Values are expressed as mean ± S.D. of three independent experiments, each performed in triplicate (n = 9).
Effects of peniocerol and macdougallin on cell cycle distribution.
| Compound | Cell cycle phase (%) | |||||
|---|---|---|---|---|---|---|
| HCT-15 | MCF-7 | |||||
| G1 | S | G2/M | G1 | S | G2/M | |
| Control (DMSO) | ||||||
| 24 h | 49.82 ± 0.61 | 22.05 ± 0.14 | 28.72 ± 0.40 | 59.6 ± 0.78 | 15.61 ± 0.86 | 25.22 ± 0.36 |
|
| ||||||
| Peniocerol (1) | ||||||
| 40 | 80.63 ± 0.61 | 13.92 ± 0.85 | 5.56 ± 0.22 | 75.29 ± 1.65 | 8.93 ± 1.05 | 16.10 ± 0.80 |
| 60 | 84.13 ± 2.30 | 6.39 ± 4.21 | 5.84 ± 3.49 | 78.49 ± 0.70 | 6.53 ± 0.08 | 15.19 ± 0.72 |
|
| ||||||
| Macdougallin (2) | ||||||
| 40 | 64.17 ± 5.39 | 10.89 ± 0.79 | 25.22 ± 4.60 | 78.34 ± 1.28 | 12.49 ± 1.19 | 9.55 ± 1.49 |
| 60 | 68.61 ± 2.65 | 7.93 ± 0.12 | 23.16 ± 2.62 | 80.28 ± 1.04 | 10.49 ± 0.59 | 9.44 ± 0.57 |
|
| ||||||
| Timidine | ||||||
| 2 mM | 82.18 ± 1.09 | 13.84 ± 1.76 | 4.45 ± 1.94 | 70.16 ± 1.50 | 17.34 ± 0.67 | 13.05 ± 1.24 |
|
| ||||||
| Nocodazol | ||||||
| 100 ng/mL | 9.2 ± 0.85 | 17.59 ± 1.59 | 73.63 ± 2.51 | 3.90 ± 0.92 | 3.95 ± 1.80 | 92.21 ± 1.54 |
Values are expressed as mean + S.D. of three independent experiments, each made in triplicate. Untreated cells were used as a control. Significant difference with untreated group (P < 0.05). aSignificant difference with treated group at 24 h (P < 0.05).
Figure 3Effects of peniocerol and macdougallin on HCT-15 and MCF-7 cell cycle distribution.
Figure 4PARP cleaved followed by treatment with peniocerol and macdougallin.
Figure 5